
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Post-translational modifications in bladder cancer: Expanding the tumor target repertoire
Htoo Zarni Oo, Roland Seiler, Peter C. Black, et al.
Urologic Oncology Seminars and Original Investigations (2018) Vol. 38, Iss. 12, pp. 858-866
Closed Access | Times Cited: 19
Htoo Zarni Oo, Roland Seiler, Peter C. Black, et al.
Urologic Oncology Seminars and Original Investigations (2018) Vol. 38, Iss. 12, pp. 858-866
Closed Access | Times Cited: 19
Showing 19 citing articles:
PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer
Liliang Shen, Junfeng Zhang, Zongtai Zheng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 14, pp. 5459-5474
Open Access | Times Cited: 83
Liliang Shen, Junfeng Zhang, Zongtai Zheng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 14, pp. 5459-5474
Open Access | Times Cited: 83
Lactylated Apolipoprotein C‐II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis
Jian Chen, Deping Zhao, Yupeng Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 16
Jian Chen, Deping Zhao, Yupeng Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 16
Unconventional protein post-translational modifications: the helmsmen in breast cancer
Jiena Liu, Qin Wang, Yujuan Kang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Jiena Liu, Qin Wang, Yujuan Kang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
SUMOylation of SETD8 Promotes Tumor Growth by Methylating and Stabilizing MYC in Bladder Cancer
Xia Zhang, Zhenxuan Chen, Xiaobo He, et al.
Advanced Science (2025)
Open Access
Xia Zhang, Zhenxuan Chen, Xiaobo He, et al.
Advanced Science (2025)
Open Access
USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target
Yizhi Wang, Li Zhou, Jun Lü, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Yizhi Wang, Li Zhou, Jun Lü, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Post-Translational Modifications That Drive Prostate Cancer Progression
Ivana Samaržija
Biomolecules (2021) Vol. 11, Iss. 2, pp. 247-247
Open Access | Times Cited: 32
Ivana Samaržija
Biomolecules (2021) Vol. 11, Iss. 2, pp. 247-247
Open Access | Times Cited: 32
Differences of the tumour cell glycocalyx affect binding of capsaicin-loaded chitosan nanocapsules
Lydia von Palubitzki, Yuanyuan Wang, Stefan Hoffmann, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 30
Lydia von Palubitzki, Yuanyuan Wang, Stefan Hoffmann, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 30
SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer
Qi‐Dong Xia, Jian‐Xuan Sun, Yang Xun, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Qi‐Dong Xia, Jian‐Xuan Sun, Yang Xun, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Functions and mechanisms of protein lysine butyrylation (Kbu): Therapeutic implications in human diseases
Qianqian Xue, Yanyan Yang, Hong Li, et al.
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2479-2490
Open Access | Times Cited: 14
Qianqian Xue, Yanyan Yang, Hong Li, et al.
Genes & Diseases (2022) Vol. 10, Iss. 6, pp. 2479-2490
Open Access | Times Cited: 14
The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy
Xuemei Wang, Ying Zhang, Yao Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Xuemei Wang, Ying Zhang, Yao Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
<p>The microRNA miR-3174 Suppresses the Expression of ADAM15 and Inhibits the Proliferation of Patient-Derived Bladder Cancer Cells</p>
Chunhu Yu, Ying Wang, Tiejun Liu, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 4157-4168
Open Access | Times Cited: 15
Chunhu Yu, Ying Wang, Tiejun Liu, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 4157-4168
Open Access | Times Cited: 15
Blood-based protein biomarkers in bladder urothelial tumors
Rubén López-Cortés, Benito Blanco Gómez, Sergio Vázquez‐Estévez, et al.
Journal of Proteomics (2021) Vol. 247, pp. 104329-104329
Closed Access | Times Cited: 13
Rubén López-Cortés, Benito Blanco Gómez, Sergio Vázquez‐Estévez, et al.
Journal of Proteomics (2021) Vol. 247, pp. 104329-104329
Closed Access | Times Cited: 13
The Relationship Between Capsaicin in Chili Pepper and Cancer: A Comprehensive Insight
Nevin Şanlıer, Esra Irmak, Zeynep Bengisu Ejder
Clinical and Experimental Health Sciences (2024) Vol. 14, Iss. 1, pp. 273-282
Open Access | Times Cited: 1
Nevin Şanlıer, Esra Irmak, Zeynep Bengisu Ejder
Clinical and Experimental Health Sciences (2024) Vol. 14, Iss. 1, pp. 273-282
Open Access | Times Cited: 1
Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis
Pooja Gulhane, Shailza Singh
Translational Oncology (2023) Vol. 33, pp. 101673-101673
Open Access | Times Cited: 4
Pooja Gulhane, Shailza Singh
Translational Oncology (2023) Vol. 33, pp. 101673-101673
Open Access | Times Cited: 4
Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer
Htoo Zarni Oo, Zoltán Lohinai, Nastaran Khazamipour, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4489-4489
Open Access | Times Cited: 7
Htoo Zarni Oo, Zoltán Lohinai, Nastaran Khazamipour, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4489-4489
Open Access | Times Cited: 7
DeepSSPred: A Deep Learning Based Sulfenylation Site Predictor Via a Novel nSegmented Optimize Federated Feature Encoder
Zaheer Ullah Khan, Dechang Pi
Protein and Peptide Letters (2020) Vol. 28, Iss. 6, pp. 708-721
Closed Access | Times Cited: 5
Zaheer Ullah Khan, Dechang Pi
Protein and Peptide Letters (2020) Vol. 28, Iss. 6, pp. 708-721
Closed Access | Times Cited: 5
PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target
Holger H.H. Erb, Marlies Ebert, Ronja Kuhn, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0224085-e0224085
Open Access | Times Cited: 2
Holger H.H. Erb, Marlies Ebert, Ronja Kuhn, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0224085-e0224085
Open Access | Times Cited: 2
Editorial: Basic research in bladder cancer – refining the tools. 3rd IBCN seminars series1
Peter C. Black, Peter J. Goebell, Ashish M. Kamat, et al.
Urologic Oncology Seminars and Original Investigations (2019) Vol. 38, Iss. 12, pp. 855-857
Closed Access
Peter C. Black, Peter J. Goebell, Ashish M. Kamat, et al.
Urologic Oncology Seminars and Original Investigations (2019) Vol. 38, Iss. 12, pp. 855-857
Closed Access